Get all your news in one place.
100's of premium titles.
One app.
Start reading
Top News
Top News
Health

YOU WONT BELIEVE: Fda approves first blood test for colon cancer screening | Mind Blowing Facts

A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md., Dec. 10, 2020. U.S. health regulators on Monday, July 29, 2024, approved a first-of-it

U.S. health regulators have given the green light to a groundbreaking blood test for colon cancer, marking a significant advancement in the detection of this prevalent cause of cancer-related deaths. The FDA has granted approval to the Shield test developed by Guardant, making it the first of its kind for screening adults aged 45 and above with an average risk of colon cancer.

While the Shield test does not replace the necessity of colonoscopies, it offers a noninvasive alternative for screening purposes. This innovative test, which can be ordered by doctors as a laboratory test for $895, detects DNA fragments released by tumor cells and precancerous growths.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.